144 filed Jul 27, 2026 at 16:52 ET
Chairman August J. Troendle filed a Form 144 notice of intent to sell 307,959 shares of Medpace common stock, valued at approximately $184.8 million based on the filing date. This represents a substantial proposed sale by the company's founder and chairman, signaling potential insider distribution at a $17.2B market cap company. The filing is an advance notice of intent, not a completed sale, but the magnitude relative to market cap (~1.1%) and the insider's role make it a notable event for traders to monitor for execution.